Want to see HK:1501 full AI Analyst Report?
Shanghai Kindly Medical Instruments Co., Ltd. Class H (1501) Stock Statistics & Valuation Metrics
Total Valuation
Shanghai Kindly Medical Instruments Co., Ltd. Class H has a market cap or net worth of HKD 6.34B. The enterprise value is HKD 5.57B.
- Market Cap
- HKD 6.34B
- Enterprise Value
- HKD 5.57B
Share Statistics
Shanghai Kindly Medical Instruments Co., Ltd. Class H has 211,200,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 211,200,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.26%
Financial Efficiency
Shanghai Kindly Medical Instruments Co., Ltd. Class H’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.58%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 8.58%
- Return on Capital Employed (ROCE)
- 0.12
- Revenue Per Employee
- 488.75K
- Profits Per Employee
- 100.36K
- Employee Count
- 2,180
- Asset Turnover
- 0.34
- Inventory Turnover
- 2.20
Valuation Ratios
The current PE Ratio of Shanghai Kindly Medical Instruments Co., Ltd. Class H is 21.53. Shanghai Kindly Medical Instruments Co., Ltd. Class H’s PEG ratio is 1.90.
- PE Ratio
- 21.53
- PS Ratio
- 3.50
- PB Ratio
- 1.79
- Price to FCF
- 11.06
- Price to Operating Cash Flow
- 11.06
- PEG Ratio
- 1.90
Income Statement
In the last 12 months, Shanghai Kindly Medical Instruments Co., Ltd. Class H had revenue of 1.07B and earned 218.79M in profits. Earnings per share was 1.26.
- Revenue
- 1.07B
- Gross Profit
- 636.79M
- Operating Income
- 271.45M
- Pretax Income
- 258.32M
- Net Income
- 218.79M
- EBITDA
- 362.52M
- Earnings Per Share (EPS)
- 1.26
Cash Flow
In the last 12 months, operating cash flow was 445.91M and capital expenditures -68.57M, giving a free cash flow of 377.34M billion.
- Operating Cash Flow
- 445.91M
- Free Cash Flow
- 377.34M
- Free Cash Flow per Share
- 1.94
Dividends & Yields
Shanghai Kindly Medical Instruments Co., Ltd. Class H pays an annual dividend of HKD 0.30, resulting in a dividend yield of 0.87%
- Dividend Per Share
- HKD 0.30
- Dividend Yield
- 0.87%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 9.04%
- Earnings Yield
- 4.64%
Stock Price Statistics
- Beta
- -0.02
- 52-Week Price Change
- -5.84%
- 50-Day Moving Average
- 33.08
- 200-Day Moving Average
- 32.98
- Relative Strength Index (RSI)
- 39.94
- Average Volume (3m)
- 213.51K
Important Dates
Shanghai Kindly Medical Instruments Co., Ltd. Class H upcoming earnings date is Mar 22, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 24, 2026
- Next Earnings Date
- Mar 22, 2027
- Ex-Dividend Date
- May 30, 2024
Financial Position
Shanghai Kindly Medical Instruments Co., Ltd. Class H as a current ratio of 1.26, with Debt / Equity ratio of 35.88%
- Current Ratio
- 1.26
- Quick Ratio
- 1.02
- Debt to Market Cap
- 0.15
- Net Debt to EBITDA
- 0.29
- Interest Coverage Ratio
- 21.64
Taxes
In the past 12 months, Shanghai Kindly Medical Instruments Co., Ltd. Class H has paid 25.65M in taxes.
- Income Tax
- 25.65M
- Effective Tax Rate
- 0.10
Enterprise Valuation
Shanghai Kindly Medical Instruments Co., Ltd. Class H EV to EBITDA ratio is 9.29, with an EV/FCF ratio of 9.51.
- EV to Sales
- 3.01
- EV to EBITDA
- 9.29
- EV to Free Cash Flow
- 9.51
- EV to Operating Cash Flow
- 8.04
Balance Sheet
Shanghai Kindly Medical Instruments Co., Ltd. Class H has HKD 1.32B in cash and marketable securities with HKD 716.25M in debt, giving a net cash position of HKD 606.01M billion.
- Cash & Marketable Securities
- HKD 1.32B
- Total Debt
- HKD 716.25M
- Net Cash
- HKD 606.01M
- Net Cash Per Share
- HKD 2.87
- Tangible Book Value Per Share
- HKD 10.62
Margins
Gross margin is 60.85%, with operating margin of 22.99%, and net profit margin of 19.21%.
- Gross Margin
- 60.85%
- Operating Margin
- 22.99%
- Pretax Margin
- 23.51%
- Net Profit Margin
- 19.21%
- EBITDA Margin
- 32.39%
- EBIT Margin
- 22.45%
Analyst Forecast
The average price target for Shanghai Kindly Medical Instruments Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 34.94%
- EPS Growth Forecast
- 12.99%
Scores
- Smart Score
- 4
- AI Score
- 61